SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

USFDA completes inspection at Ortin Laboratories’ Unit-II facility at Nalgonda

09 Sep 2019 Evaluate

US Food and Drug Administration (USFDA) has completed inspection at Ortin Laboratories, Unit-II Malkapur Village, Choutuppal Mandal, Nalgonda District in the state of Telangana. The inspection has been completed on September 06, 2019. After inspection the company has been issued a Form FDA 483 (9/08) with three observations.

Ortin Laboratories is a leading and predominant Pharmaceutical Manufacturer of Drugs and Medicines in India. The company is engaged in manufacture of Pharma formulations.

Ortin Global Share Price

17.77 0.57 (3.31%)
03-Jul-2026 11:53 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1912.40
Dr. Reddys Labs. 1375.05
Cipla 1461.50
Zydus Lifesciences 1127.80
Lupin 2469.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: